The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multiomics profiling of longitudinal melanoma specimens unravels molecular mechanisms of resistance to sequential targeted and cancer immunotherapies.
 
Jinho Lee
Travel, Accommodations, Expenses - NanoString Technologies
 
Marilyne Labrie
No Relationships to Disclose
 
Gen Yong
No Relationships to Disclose
 
Todd Camp
No Relationships to Disclose
 
Hongli Ma
No Relationships to Disclose
 
Megan Grout
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Georgia Beasley
Consulting or Advisory Role - Cardinal Health; Regeneron
 
Lynn Mara Schuchter
Consulting or Advisory Role - Incyte
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck (Inst)
Expert Testimony - Pfizer
 
Suzanne McGettigan
Speakers' Bureau - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck; Novartis
 
Donald M. O'Rourke
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - ErbB tumors and radiation therapy (Inst); Multiple patent applications on CART cells in solid tumors (Inst)
 
Meenhard Herlyn
Research Funding - Actelion; Bayer; GlaxoSmithKline; MTargets; Plexxikon
 
Christopher L. Corless
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Amgen; Cepheid
Research Funding - Aileron Therapeutics (Inst); Arvinas (Inst)
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; ImmunoMET; SignalChem; Spindletop Ventures; Tarveda Therapeutics
Honoraria - AstraZeneca; ImmunoMET; Lilly; Nuevolution; PDX Pharmacy; Symphogen; Tarveda Therapeutics; Tesaro
Consulting or Advisory Role - AstraZeneca; ImmunoMET; Lilly; PDX Pharmacy; SignalChem; Symphogen; Takeda/Millennium; Tarveda Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; ImmunoMET; Ions Pharmaceuticals; Karus Therapeutics; NanoString Technologies; Pfizer; Prospect Creek Foundation; Tarveda Therapeutics
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen
 
Gao Zhang
No Relationships to Disclose